CytoSorbents, Inc. Appoints Dr. Rainer Kosanke as European Director of Scientific Affairs
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MONMOUTH JUNCTION, N.J., July 8, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company commercializing its European Union approved CytoSorb® blood filter to treat life-threatening illnesses in the intensive care unit, announced today that its wholly-owned subsidiary, CytoSorbents Europe GmbH has appointed Dr. Rainer Kosanke, PhD, as European Director of Scientific Affairs.
Help employers find you! Check out all the jobs and post your resume.
MONMOUTH JUNCTION, N.J., July 8, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company commercializing its European Union approved CytoSorb® blood filter to treat life-threatening illnesses in the intensive care unit, announced today that its wholly-owned subsidiary, CytoSorbents Europe GmbH has appointed Dr. Rainer Kosanke, PhD, as European Director of Scientific Affairs.
Help employers find you! Check out all the jobs and post your resume.